Kevin Tang increases his stake in Boundless Bio, reflecting confidence in the pharmaceutical sector. The filing details his recent stock purchases.
| Name | Boundless Bio, Inc. |
|---|---|
| CIK | 0001782303 |
| Tickers | BOLD |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 830751369 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | (858) 766-9912 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Kevin Tang increases his stake in Boundless Bio, reflecting confidence in the pharmaceutical sector. The filing details his recent stock purchases.
Kevin Tang boosts his stake in Boundless Bio, reflecting confidence in the company's future. This move may influence the pharmaceutical preparations sector.
Boundless Bio, Inc. shares its Q3 2026 financial results, showcasing its ongoing commitment to innovation in the pharmaceutical preparations sector.
Kevin Tang, a significant stakeholder in Boundless Bio, has made notable stock purchases, signaling confidence in the company's future in the pharmaceutical sector.
Boundless Bio, Inc. secures SEC effectiveness for its S-4 registration statement, paving the way for upcoming securities offerings.
Boundless Bio, Inc. announces a merger with Serapha Bio, Inc., aiming to strengthen its position in the pharmaceutical sector. Shareholders to vote in December.
Boundless Bio, Inc. files an amended registration statement as it prepares for a significant merger, highlighting strategic moves in the pharmaceutical industry.
Kevin Tang of Boundless Bio, Inc. purchases over 10,000 shares, signaling confidence in the pharmaceutical preparations sector amid market fluctuations.
Boundless Bio, Inc. has filed a prospectus for a potential business combination, indicating growth in the pharmaceutical preparations sector.
Boundless Bio, Inc. files a prospectus for business combinations, indicating strategic growth in the pharmaceutical preparations sector.
Boundless Bio, Inc. reveals insider stock purchases by Kevin Tang, signaling strong investment interest in the pharmaceutical sector.
Boundless Bio, Inc. reveals recent stock purchases by major stakeholders, indicating strong investment interest in the pharmaceutical sector.
166 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-17 | 4 | xslF345X06/form4-11172026_101103.xml | 0001178579-26-000025 | 9404 | ||||||
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001214659-26-014412 | 005-94492 | 261561113 | 34 | 14504 | |||
| 2026-11-10 | 4 | xslF345X06/form4-11102026_101130.xml | 0001178579-26-000024 | 9402 | ||||||
| 2026-11-10 | 10-Q | 10-Q | 0001193125-26-454406 | 001-41989 | 261537910 | 34 | 8418936 | 1 | 1 | |
| 2026-11-05 | 4 | xslF345X06/form4-11052026_111112.xml | 0001178579-26-000023 | 11160 | ||||||
| 2026-11-03 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-003420 | 333-299369 | 261519794 | 33 | 1768 | ||
| 2026-11-03 | 424B3 | 424B3 | 0001193125-26-445503 | 333-299369 | 261518343 | 33 | 9717485 | |||
| 2026-11-02 | S-4/A | S-4/A | 0001193125-26-442255 | 333-299369 | 261509696 | 33 | 22886030 | 1 | 1 | |
| 2026-10-29 | 4 | xslF345X06/form4-10292026_101050.xml | 0001178579-26-000022 | 7749 | ||||||
| 2026-10-26 | 425 | 425 | 0001193125-26-432157 | 001-41989 | 261486647 | 34 | 323276 | |||
| 2026-10-26 | 4 | xslF345X06/form4-10262026_081059.xml | 0001178579-26-000020 | 11161 | ||||||
| 2026-10-26 | 425 | 425 | 0001193125-26-431041 | 001-41989 | 261483560 | 34 | 39030 | |||
| 2026-10-20 | 4 | xslF345X06/form4-10202026_091022.xml | 0001178579-26-000019 | 13174 | ||||||
| 2026-10-08 | S-4 | S-4 | 0001193125-26-417903 | 333-299369 | 261449938 | 33 | 24018773 | 1 | 1 | |
| 2026-08-31 | DRS | filename1.htm | 0001193125-26-375323 | 377-09719 | 261342434 | 33 | 10806168 | |||
| 2026-08-28 | 425 | 425 | 0001193125-26-374789 | 001-41989 | 261341615 | 34 | 159122 | |||
| 2026-08-28 | 8-K | 8-K | 1.01,9.01 | 0001193125-26-374787 | 001-41989 | 261341603 | 34 | 320731 | 1 | 1 |
| 2026-08-28 | 4 | xslF345X06/form4-08282026_080804.xml | 0001178579-26-000018 | 7977 | ||||||
| 2026-08-27 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-371863 | 005-94492 | 261332576 | 34 | 7295 | |||
| 2026-08-14 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-097418 | 005-94492 | 261284489 | 34 | 14739 | |||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-097051 | 005-94492 | 261280904 | 34 | 18052 | |||
| 2026-08-07 | 10-Q | 10-Q | 0001193125-26-339093 | 001-41989 | 261251354 | 34 | 8660184 | 1 | 1 | |
| 2026-07-21 | 4 | xslF345X06/form4-07212026_110753.xml | 0001178579-26-000017 | 10836 | ||||||
| 2026-07-16 | 4 | xslF345X06/form4-07172026_120745.xml | 0001178579-26-000015 | 11114 | ||||||
| 2026-07-13 | 4 | xslF345X06/form4-07132026_110705.xml | 0001178579-26-000011 | 11111 | ||||||
| 2026-07-08 | 4 | xslF345X06/form4-07092026_120702.xml | 0001178579-26-000010 | 11144 | ||||||
| 2026-07-06 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001012975-26-000622 | 19854 | ||||||
| 2026-07-06 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001012975-26-000621 | 26862 | ||||||
| 2026-07-02 | 4 | xslF345X06/form4-07022026_110743.xml | 0001178579-26-000009 | 12783 | ||||||
| 2026-06-29 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001214659-26-007864 | 005-94492 | 261137546 | 34 | 27763 | |||
| 2026-06-29 | 4 | xslF345X06/form4-06292026_110657.xml | 0001178579-26-000008 | 16215 | ||||||
| 2026-06-29 | 3 | xslF345X06/form3-06292026_110621.xml | 0001178579-26-000007 | 6411 | ||||||
| 2026-06-23 | 425 | 425 | 0001193125-26-278575 | 001-41989 | 261109017 | 34 | 1132384 | |||
| 2026-06-23 | 8-K | 8-K | 1.01,2.05,3.02,5.01,5.02,7.01,8.01,9.01 | 0001193125-26-278570 | 001-41989 | 261109002 | 34 | 1551346 | 1 | 1 |
| 2026-06-17 | 8-K | 8-K | 5.07 | 0001193125-26-273544 | 001-41989 | 261096952 | 34 | 201360 | 1 | 1 |
| 2026-06-15 | 4 | 4 | 0001193125-26-271474 | 5613 | ||||||
| 2026-06-15 | 4 | 4 | 0001193125-26-271465 | 5716 | ||||||
| 2026-06-15 | 4 | 4 | 0001193125-26-271457 | 5653 | ||||||
| 2026-06-15 | 4 | 4 | 0001193125-26-271453 | 5653 | ||||||
| 2026-05-08 | 10-Q | 10-Q | 0001193125-26-213321 | 001-41989 | 26956028 | 34 | 6698906 | 1 | 1 | |
| 2026-05-08 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-213269 | 001-41989 | 26956011 | 34 | 419547 | 1 | 1 |
| 2026-04-28 | ARS | ARS | 0001193125-26-187010 | 001-41989 | 26907768 | 34 | 5343577 | |||
| 2026-04-28 | DEFA14A | DEFA14A | 0001193125-26-186925 | 001-41989 | 26907558 | 34 | 1877307 | |||
| 2026-04-28 | DEF 14A | DEF 14A | 0001193125-26-186884 | 001-41989 | 26907441 | 34 | 5041618 | 1 | 1 | |
| 2026-04-13 | 8-K | 8-K | 1.02,2.03 | 0001193125-26-153076 | 001-41989 | 26858505 | 34 | 151982 | 1 | 1 |
| 2026-03-09 | 10-K | 10-K | 0001193125-26-097543 | 001-41989 | 26733167 | 34 | 25637024 | 1 | 1 | |
| 2026-03-09 | 8-K | 8-K | 2.02,5.02,9.01 | 0001193125-26-097535 | 001-41989 | 26733160 | 34 | 483833 | 1 | 1 |
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001826420-26-000005 | 005-94492 | 26644443 | 34 | 14144 | |||
| 2026-02-05 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000315066-26-000366 | 005-94492 | 26601836 | 34 | 11623 | |||
| 2026-01-26 | 4 | 4 | 0001193125-26-021658 | 5353 | ||||||
| 2026-01-26 | 4 | 4 | 0001193125-26-021657 | 5368 | ||||||
| 2026-01-26 | 4 | 4 | 0001193125-26-021656 | 5327 | ||||||
| 2026-01-26 | 4 | 4 | 0001193125-26-021655 | 5334 | ||||||
| 2026-01-26 | 4 | 4 | 0001193125-26-021654 | 5412 | ||||||
| 2025-12-04 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-118546 | 005-94492 | 251550896 | 34 | 27320 | |||
| 2025-11-05 | 10-Q | 10-Q | 0001193125-25-265714 | 001-41989 | 251451759 | 34 | 8014149 | 1 | 1 | |
| 2025-11-05 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-265707 | 001-41989 | 251451743 | 34 | 477976 | 1 | 1 |
| 2025-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001415889-25-022005 | 005-94492 | 251221469 | 34 | 12662 | |||
| 2025-08-05 | 10-Q | 10-Q | 0000950170-25-102391 | 001-41989 | 251182770 | 34 | 7686009 | 1 | 1 | |
| 2025-08-05 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-102386 | 001-41989 | 251182756 | 34 | 476560 | 1 | 1 |
| 2025-06-23 | 4 | 4 | 0000950170-25-089089 | 5513 | ||||||
| 2025-06-23 | 4 | 4 | 0000950170-25-089085 | 5495 | ||||||
| 2025-06-23 | 4 | 4 | 0000950170-25-089082 | 5456 | ||||||
| 2025-06-23 | 4 | 4 | 0000950170-25-089077 | 5558 | ||||||
| 2025-06-23 | 4 | 4 | 0000950170-25-089072 | 5474 | ||||||
| 2025-06-23 | 4 | 4 | 0000950170-25-089067 | 5455 | ||||||
| 2025-06-23 | 8-K | 8-K | 5.07 | 0000950170-25-089002 | 001-41989 | 251065207 | 34 | 175571 | 1 | 1 |
| 2025-05-23 | 8-K | 8-K | 2.05,8.01 | 0000950170-25-076911 | 001-41989 | 25982163 | 34 | 165793 | 1 | 1 |
| 2025-05-09 | 10-Q | 10-Q | 0000950170-25-067496 | 001-41989 | 25928362 | 34 | 7793980 | 1 | 1 | |
| 2025-05-09 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-067495 | 001-41989 | 25928335 | 34 | 431224 | 1 | 1 |
| 2025-04-29 | ARS | ARS | 0000950170-25-060114 | 001-41989 | 25887467 | 34 | 10134170 | |||
| 2025-04-29 | DEFA14A | DEFA14A | 0000950170-25-060089 | 001-41989 | 25887091 | 34 | 1069353 | |||
| 2025-04-29 | DEF 14A | DEF 14A | 0000950170-25-060073 | 001-41989 | 25886928 | 34 | 4244681 | 1 | 1 | |
| 2025-04-10 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-001071 | 333-286302 | 25829671 | 33 | 1751 | ||
| 2025-04-08 | CORRESP | filename1.htm | 0001193125-25-075712 | 6873 | ||||||
| 2025-04-08 | UPLOAD | filename1.pdf | 0000000000-25-003738 | 333-286302 | 40039 | |||||
| 2025-04-01 | 8-K | 8-K | 1.01,9.01 | 0001193125-25-070496 | 001-41989 | 25800361 | 34 | 156432 | 1 | 1 |
| 2025-04-01 | S-3 | S-3 | 0001193125-25-070393 | 333-286302 | 25799528 | 33 | 1007977 | |||
| 2025-03-27 | 10-K | 10-K | 0000950170-25-045725 | 001-41989 | 25775249 | 34 | 45838683 | 1 | 1 | |
| 2025-03-27 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-045722 | 001-41989 | 25775234 | 34 | 481236 | 1 | 1 |
| 2025-02-03 | 4 | 4 | 0000950170-25-012568 | 5409 | ||||||
| 2025-02-03 | 3 | 3 | 0000950170-25-012557 | 17386 | ||||||
| 2025-01-23 | 4 | 4 | 0000950170-25-008320 | 5269 | ||||||
| 2025-01-23 | 4 | 4 | 0000950170-25-008319 | 5241 | ||||||
| 2025-01-23 | 4 | 4 | 0000950170-25-008318 | 5220 | ||||||
| 2025-01-23 | 4 | 4 | 0000950170-25-008317 | 5248 | ||||||
| 2025-01-23 | UPLOAD | filename1.pdf | 0000000000-25-000735 | 005-94492 | 42799 | |||||
| 2024-12-12 | 8-K | 8-K | 5.02,7.01,8.01,9.01 | 0000950170-24-135768 | 001-41989 | 241544817 | 34 | 269644 | 1 | 1 |
| 2024-11-07 | 10-Q | 10-Q | 0000950170-24-123291 | 001-41989 | 241435568 | 34 | 6808205 | 1 | 1 | |
| 2024-11-07 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-123274 | 001-41989 | 241435493 | 34 | 352941 | 1 | 1 |
| 2024-10-29 | SC 13D | ARCH VENTURE FUND IX, L.P. - BOUNDLESS BIO -- SCH 13D | 0001072613-24-000789 | 005-94492 | 241406995 | 34 | 484016 | |||
| 2024-10-15 | 3 | 3 | 0000950170-24-114468 | 26546 | ||||||
| 2024-10-15 | 8-K | 8-K | 5.02 | 0000950170-24-114466 | 001-41989 | 241369334 | 34 | 159260 | 1 | 1 |
| 2024-08-20 | 4 | 4 | 0000950170-24-099308 | 25212 | ||||||
| 2024-08-20 | 4 | 4 | 0000950170-24-099307 | 33575 | ||||||
| 2024-08-20 | 4 | 4 | 0000950170-24-099306 | 20947 | ||||||
| 2024-08-20 | 4 | 4 | 0000950170-24-099303 | 25158 | ||||||
| 2024-08-20 | 4 | 4 | 0000950170-24-099299 | 25274 | ||||||
| 2024-08-20 | 4 | 4 | 0000950170-24-099296 | 16973 | ||||||
| 2024-08-20 | 8-K | 8-K | 5.02 | 0000950170-24-099185 | 001-41989 | 241225979 | 34 | 152129 | 1 | 1 |
| 2024-08-12 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-095481 | 001-41989 | 241197138 | 34 | 360773 | 1 | 1 |
| 2024-08-12 | 10-Q | 10-Q | 0000950170-24-095421 | 001-41989 | 241196859 | 34 | 6581660 | 1 | 1 | |
| 2024-06-20 | 4 | 4 | 0000950170-24-075800 | 5443 | ||||||
| 2024-05-13 | 10-Q | 10-Q | 0000950170-24-058188 | 001-41989 | 24936847 | 34 | 6368311 | 1 | 1 | |
| 2024-05-13 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-24-058186 | 001-41989 | 24936844 | 34 | 367967 | 1 | 1 |
| 2024-04-12 | SC 13G | SC 13G | 0001104659-24-046791 | 005-94492 | 24841806 | 34 | 91427 | |||
| 2024-04-12 | SC 13G | SC 13G | 0001104659-24-046767 | 005-94492 | 24841640 | 34 | 113846 | |||
| 2024-04-10 | SC 13G | filing.txt | 0000315066-24-001708 | 005-94492 | 24834457 | 34 | 8152 | |||
| 2024-04-09 | SC 13G | SC 13G | 0001104659-24-045227 | 005-94492 | 24832898 | 34 | 77832 | |||
| 2024-04-04 | 4 | 4 | 0000950170-24-041844 | 30726 | ||||||
| 2024-04-04 | 4 | 4 | 0000950170-24-041843 | 12613 | ||||||
| 2024-04-04 | 4 | 4 | 0000950170-24-041842 | 33971 | ||||||
| 2024-04-04 | 4 | 4 | 0000950170-24-041841 | 42413 | ||||||
| 2024-04-04 | 4 | xslF345X05/form4-04042024_040402.xml | 0001415889-24-010278 | 26304 | ||||||
| 2024-04-02 | 4 | xslF345X05/form4-04032024_120459.xml | 0001415889-24-009885 | 11407 | ||||||
| 2024-04-02 | 8-K | 8-K | 5.03,8.01,9.01 | 0001193125-24-084736 | 001-41989 | 24814066 | 34 | 419033 | 1 | 1 |
| 2024-03-29 | 4 | 4 | 0000950170-24-038705 | 5225 | ||||||
| 2024-03-29 | 4 | 4 | 0000950170-24-038703 | 5126 | ||||||
| 2024-03-29 | 4 | 4 | 0000950170-24-038698 | 5183 | ||||||
| 2024-03-29 | 4 | 4 | 0000950170-24-038697 | 5144 | ||||||
| 2024-03-29 | 4 | 4 | 0000950170-24-038702 | 5215 | ||||||
| 2024-03-29 | 4 | 4 | 0000950170-24-038696 | 5227 | ||||||
| 2024-03-29 | 4 | 4 | 0000950170-24-038701 | 5181 | ||||||
| 2024-03-29 | 4 | 4 | 0000950170-24-038699 | 5256 | ||||||
| 2024-03-29 | 4 | 4 | 0000950170-24-038695 | 5192 | ||||||
| 2024-03-29 | 4 | 4 | 0000950170-24-038700 | 5233 | ||||||
| 2024-03-29 | 4 | 4 | 0000950170-24-038693 | 5125 | ||||||
| 2024-03-29 | 4 | 4 | 0000950170-24-038692 | 5241 | ||||||
| 2024-03-28 | S-8 | S-8 | 0001193125-24-080893 | 333-278354 | 24800586 | 33 | 291906 | |||
| 2024-03-28 | 424B4 | 424B4 | 0001193125-24-080798 | 333-277696 | 24799986 | 33 | 9444292 | |||
| 2024-03-27 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2024-03-27 16:00:00 | 9999999995-24-000741 | 333-277696 | 24793228 | 33 | 1764 | ||
| 2024-03-27 | 3 | xslF345X02/form3-03282024_010328.xml | 0001415889-24-009285 | 6626 | ||||||
| 2024-03-27 | 3 | xslF345X02/form3-03282024_120342.xml | 0001415889-24-009276 | 15860 | ||||||
| 2024-03-27 | 3 | 3 | 0000950170-24-037509 | 21945 | ||||||
| 2024-03-27 | 3 | 3 | 0000950170-24-037507 | 16773 | ||||||
| 2024-03-27 | 3 | 3 | 0000950170-24-037506 | 31775 | ||||||
| 2024-03-27 | 3 | 3 | 0000950170-24-037505 | 19088 | ||||||
| 2024-03-27 | 3 | 3 | 0000950170-24-037500 | 22258 | ||||||
| 2024-03-27 | 3 | 3 | 0000950170-24-037498 | 20661 | ||||||
| 2024-03-27 | 3 | 3 | 0000950170-24-037494 | 23008 | ||||||
| 2024-03-27 | 3 | 3 | 0000950170-24-037491 | 26003 | ||||||
| 2024-03-27 | 3 | 3 | 0000950170-24-037487 | 19811 | ||||||
| 2024-03-27 | 3 | 3 | 0000950170-24-037485 | 23683 | ||||||
| 2024-03-27 | 3 | 3 | 0000950170-24-037484 | 20247 | ||||||
| 2024-03-27 | 3 | 3 | 0000950170-24-037478 | 21788 | ||||||
| 2024-03-27 | 3 | 3 | 0000950170-24-037472 | 28627 | ||||||
| 2024-03-27 | 3 | 3 | 0000950170-24-037467 | 20059 | ||||||
| 2024-03-27 | CERT | 8A_CERT_BOLD.pdf | 0001354457-24-000207 | 001-41989 | 24789729 | 34 | 217994 | |||
| 2024-03-25 | CORRESP | filename1.htm | 0001193125-24-076458 | 10308 | ||||||
| 2024-03-25 | CORRESP | filename1.htm | 0001193125-24-076457 | 7334 | ||||||
| 2024-03-22 | 8-A12B | 8-A12B | 0001193125-24-075413 | 001-41989 | 24776061 | 34 | 14168 | |||
| 2024-03-21 | S-1/A | S-1/A | 0001193125-24-073230 | 333-277696 | 24769303 | 33 | 11277145 | |||
| 2024-03-15 | CORRESP | filename1.htm | 0001193125-24-068520 | 24369 | ||||||
| 2024-03-13 | UPLOAD | filename1.pdf | 0000000000-24-002778 | 377-06851 | 43910 | |||||
| 2024-03-08 | CORRESP | filename1.htm | 0001193125-24-063723 | 74342 | ||||||
| 2024-03-06 | CORRESP | filename1.htm | 0001193125-24-060721 | 25421 | ||||||
| 2024-03-06 | S-1 | S-1 | 0001193125-24-060708 | 333-277696 | 24725888 | 33 | 11626503 | |||
| 2024-01-29 | UPLOAD | filename1.pdf | 0000000000-24-001096 | 377-06851 | 42758 | |||||
| 2024-01-23 | DRS/A | filename1.htm | 0000950123-24-000290 | 377-06851 | 24550297 | 33 | 9594524 | |||
| 2023-10-11 | DRSLTR | filename1.htm | 0000950123-23-008797 | 59122 | ||||||
| 2023-10-11 | DRS/A | filename1.htm | 0000950123-23-008796 | 377-06851 | 231321193 | 33 | 9468794 | |||
| 2023-09-29 | UPLOAD | filename1.pdf | 0000000000-23-010853 | 377-06851 | 60996 | |||||
| 2023-09-01 | DRS | filename1.htm | 0000950123-23-008432 | 377-06851 | 231233311 | 33 | 10764787 | |||
| 2023-08-15 | D | xslFormDX01/primary_doc.xml | 06b | 0001567619-23-006940 | 021-489721 | 231172982 | 33 | 10817 | ||
| 2021-05-04 | D | xslFormDX01/primary_doc.xml | 06b | 0001567619-21-008997 | 021-398232 | 21889671 | 33 | 10197 | ||
| 2020-03-12 | D | xslFormDX01/primary_doc.xml | 06b | 0001567619-20-006172 | 021-362715 | 20708706 | 33 | 11750 |
One latest value per concept from companyfacts (194 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 23.61M | 2026-11-06 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 18.00M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-097543 | |
| ffd | NetFeeAmt | NetFeeAmt | USD | 0.01 | 2026-10-29 | S-4/A | 2026-11-02 | 0001193125-26-442255 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 0.04 | 2026-10-29 | S-4/A | 2026-11-02 | 0001193125-26-442255 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 282.23 | 2026-10-29 | S-4/A | 2026-11-02 | 0001193125-26-442255 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-10-29 | S-4/A | 2026-11-02 | 0001193125-26-442255 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0.03 | 2026-10-29 | S-4/A | 2026-11-02 | 0001193125-26-442255 | |||
| us-gaap | AccountsPayableAndAccruedLiabilitiesCurrent | Accounts Payable and Accrued Liabilities, Current | USD | 1.19M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 814,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 559,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -19,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 364.02M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions | APIC, Share-based Payment Arrangement, Recognition and Exercise | USD | 6,000 | 2024-01-01 | 2024-12-31 | S-4/A | 2026-11-02 | 0001193125-26-442255 | ||
| us-gaap | AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition | USD | 284,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | USD | 12.30M | 2024-01-01 | 2024-12-31 | S-4/A | 2026-11-02 | 0001193125-26-442255 | ||
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 4.88M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 5.31M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | Assets | Assets | USD | 63.59M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 63.59M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 19,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 59.08M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 59.06M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 0 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-11-02 | 0001193125-26-442255 | ||
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 34.91M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 62.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 34.91M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 16.48M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 8.53M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 700.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 23.11M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 23.11M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 2,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -42.70M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-097543 |
| us-gaap | CurrentForeignTaxExpenseBenefit | Current Foreign Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-097543 |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-097543 |
| us-gaap | CurrentStateAndLocalTaxExpenseBenefit | Current State and Local Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-097543 |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss | Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss | USD | 28.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions | Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions | Securities | 8 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | DeferredCostsCurrent | Deferred Costs, Current | USD | 5.28M | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-13 | 0000950170-24-058188 | |
| us-gaap | DeferredFederalIncomeTaxExpenseBenefit | Deferred Federal Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-097543 |
| us-gaap | DeferredForeignIncomeTaxExpenseBenefit | Deferred Foreign Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-097543 |
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-097543 |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 12.35M | 2025-12-31 | S-4/A | 2026-11-02 | 0001193125-26-442255 | |||
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-27 | 0000950170-25-045725 | |
| us-gaap | DeferredStateAndLocalIncomeTaxExpenseBenefit | Deferred State and Local Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-097543 |
| us-gaap | DeferredTaxAssetsGoodwillAndIntangibleAssets | Deferred Tax Assets, Goodwill and Intangible Assets | USD | 39,000 | 2025-12-31 | S-4/A | 2026-11-02 | 0001193125-26-442255 | |||
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 87.50M | 2025-12-31 | S-4/A | 2026-11-02 | 0001193125-26-442255 | |||
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 15.73M | 2025-12-31 | S-4/A | 2026-11-02 | 0001193125-26-442255 | |||
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2025-12-31 | S-4/A | 2026-11-02 | 0001193125-26-442255 | |||
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 12.35M | 2025-12-31 | S-4/A | 2026-11-02 | 0001193125-26-442255 | |||
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 45.57M | 2025-12-31 | S-4/A | 2026-11-02 | 0001193125-26-442255 | |||
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 2.27M | 2025-12-31 | S-4/A | 2026-11-02 | 0001193125-26-442255 | |||
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 10.12M | 2025-12-31 | S-4/A | 2026-11-02 | 0001193125-26-442255 | |||
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 75.15M | 2025-12-31 | S-4/A | 2026-11-02 | 0001193125-26-442255 | |||
| us-gaap | DeferredTaxLiabilitiesLeasingArrangements | Deferred Tax Liabilities, Leasing Arrangements | USD | 12.26M | 2025-12-31 | S-4/A | 2026-11-02 | 0001193125-26-442255 | |||
| us-gaap | DeferredTaxLiabilitiesPropertyPlantAndEquipment | Deferred Tax Liabilities, Property, Plant and Equipment | USD | 91,000 | 2025-12-31 | S-4/A | 2026-11-02 | 0001193125-26-442255 | |||
| us-gaap | Depreciation | Depreciation | USD | 528,000 | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-12 | 0000950170-24-095421 |
| us-gaap | DepreciationAndAmortization | Depreciation, Depletion and Amortization, Nonproduction | USD | 1.60M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 1.64M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | DividendsPreferredStock | Dividends, Preferred Stock | USD | 0 | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-13 | 0000950170-24-058188 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -1.89 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -1.89 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-11-02 | 0001193125-26-442255 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-11-02 | 0001193125-26-442255 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.206 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-11-02 | 0001193125-26-442255 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | 0.002 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-11-02 | 0001193125-26-442255 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.009 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-27 | 0000950170-25-045725 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-11-02 | 0001193125-26-442255 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount | USD | 1.14M | 2025-01-01 | 2025-12-31 | S-4/A | 2026-11-02 | 0001193125-26-442255 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent | pure | -0.02 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-11-02 | 0001193125-26-442255 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0.063 | 2024-01-01 | 2024-12-31 | S-4/A | 2026-11-02 | 0001193125-26-442255 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Percent | pure | -0.016 | 2024-01-01 | 2024-12-31 | S-4/A | 2026-11-02 | 0001193125-26-442255 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Percent | pure | -0.021 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-11-02 | 0001193125-26-442255 | ||
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 682,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | GainLossOnSaleOfPropertyPlantEquipment | Gain (Loss) on Disposition of Property Plant Equipment | USD | 265,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 19.91M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | ImpairmentOfLongLivedAssetsHeldForUse | Impairment of Long-Lived Assets Held-for-use | USD | 1.63M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | IncomeTaxExaminationInterestAccrued | Income Tax Examination, Interest Accrued | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-097543 | |
| us-gaap | IncomeTaxExaminationPenaltiesAccrued | Income Tax Examination, Penalties Accrued | USD | 0 | 2025-12-31 | S-4/A | 2026-11-02 | 0001193125-26-442255 | |||
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-11-02 | 0001193125-26-442255 | ||
| us-gaap | IncomeTaxPaidFederalAfterRefundReceived | IncomeTaxPaidFederalAfterRefundReceived | USD | 0 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-11-02 | 0001193125-26-442255 | ||
| us-gaap | IncomeTaxPaidForeignAfterRefundReceived | IncomeTaxPaidForeignAfterRefundReceived | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-097543 |
| us-gaap | IncomeTaxPaidStateAndLocalAfterRefundReceived | IncomeTaxPaidStateAndLocalAfterRefundReceived | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-09 | 0001193125-26-097543 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 11.97M | 2025-01-01 | 2025-12-31 | S-4/A | 2026-11-02 | 0001193125-26-442255 | ||
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -12.22M | 2025-01-01 | 2025-12-31 | S-4/A | 2026-11-02 | 0001193125-26-442255 | ||
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | -93,000 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-11-02 | 0001193125-26-442255 | ||
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | 1,000 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-11-02 | 0001193125-26-442255 | ||
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | -4.13M | 2024-01-01 | 2024-12-31 | S-4/A | 2026-11-02 | 0001193125-26-442255 | ||
| us-gaap | IncomeTaxReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Amount | USD | 1.06M | 2024-01-01 | 2024-12-31 | S-4/A | 2026-11-02 | 0001193125-26-442255 | ||
| us-gaap | IncomeTaxReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Amount | USD | 1.22M | 2025-01-01 | 2025-12-31 | S-4/A | 2026-11-02 | 0001193125-26-442255 | ||
| us-gaap | IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Accounts Payable and Accrued Liabilities | USD | -7.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | IncreaseDecreaseInDeferredIncomeTaxes | Increase (Decrease) in Deferred Income Taxes | USD | 16.30M | 2025-01-01 | 2025-12-31 | S-4/A | 2026-11-02 | 0001193125-26-442255 | ||
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -12.44M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | -1.34M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 2.18M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | LeaseCost | Lease, Cost | USD | 10.10M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | Liabilities | Liabilities | USD | 1.87M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 63.59M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 1.87M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 886,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 62.42M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -46.83M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -42.61M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 2.45M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 45.06M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -45.06M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 8.10M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 13.40M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.083 | 2025-12-31 | S-4/A | 2026-11-02 | 0001193125-26-442255 | |||
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 372,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | OtherAssets | Other Assets | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent | USD | 13,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | -83,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | OtherNoncashIncomeExpense | Other Noncash Income (Expense) | USD | -102,000 | 2024-01-01 | 2024-12-31 | S-4/A | 2026-11-02 | 0001193125-26-442255 | ||
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | 266,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | PaymentsForRent | Payments for Rent | USD | 2.90M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 3.35M | 2024-01-01 | 2024-12-31 | S-4/A | 2026-11-02 | 0001193125-26-442255 | ||
| us-gaap | PaymentsToAcquireInvestments | Payments to Acquire Investments | USD | 37.80M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 46,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | PreferredStockDividendRatePercentage | Preferred Stock, Dividend Rate, Percentage | pure | 0.06 | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-13 | 0000950170-24-058188 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 70.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 700,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 93.00M | 2024-01-01 | 2024-12-31 | S-4/A | 2026-11-02 | 0001193125-26-442255 | ||
| us-gaap | ProceedsFromIssuanceOfConvertiblePreferredStock | Proceeds from Issuance of Convertible Preferred Stock | USD | 99.67M | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-27 | 0000950170-25-045725 |
| us-gaap | ProceedsFromSaleMaturityAndCollectionsOfInvestments | Proceeds from Sale, Maturity and Collection of Investments | USD | 100.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | ProceedsFromSaleOfPropertyPlantAndEquipment | Proceeds from Sale of Property, Plant, and Equipment | USD | 265,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 849,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | ProceedsFromStockPlans | Proceeds from Stock Plans | USD | 37,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -5.36M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 25.15M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | RestrictedCash | Restricted Cash | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | RestrictedCashNoncurrent | Restricted Cash, Noncurrent | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -302.28M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 47.59M | 2024-01-01 | 2024-12-31 | S-4/A | 2026-11-02 | 0001193125-26-442255 | ||
| us-gaap | SecurityDeposit | Security Deposit | USD | 500 | 2026-06-30 | S-4/A | 2026-11-02 | 0001193125-26-442255 | |||
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 4.88M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 1.07 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.04 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 1.98M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 5.31M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 2.99 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 900,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | shares | 236,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | USD/shares | 5.04 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 1.98M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 1.05 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 1.98M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 5.31M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 2.99 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 1.98M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 5.31M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 2.99 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 1.27 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 1.27 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | SharesOutstanding | Shares, Outstanding | shares | 22.48M | 2026-06-30 | S-4/A | 2026-11-02 | 0001193125-26-442255 | |||
| us-gaap | ShortTermInvestments | Short-term Investments | USD | 27.98M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | ShortTermLeaseCost | Short-term Lease, Cost | USD | 600,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 61.72M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | USD | 61.72M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.05 | 2024-03-19 | 2025 | Q1 | 10-Q | 2025-05-09 | 0000950170-25-067496 | |
| us-gaap | StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans | Stock Issued During Period, Shares, Employee Stock Purchase Plans | shares | 35,000 | 2026-04-01 | 2026-06-30 | S-4/A | 2026-11-02 | 0001193125-26-442255 | ||
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 667,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 247.62M | 2024-01-01 | 2024-12-31 | S-4/A | 2026-11-02 | 0001193125-26-442255 | ||
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 37,000 | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 87.69M | 2024-01-01 | 2024-12-31 | S-4/A | 2026-11-02 | 0001193125-26-442255 | ||
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 813,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-27 | 0000950170-25-045725 | |
| us-gaap | TemporaryEquityLiquidationPreference | Temporary Equity, Liquidation Preference | USD | 252.10M | 2023-12-31 | 2024 | FY | 10-K | 2025-03-27 | 0000950170-25-045725 | |
| us-gaap | TemporaryEquityParOrStatedValuePerShare | Temporary Equity, Par or Stated Value Per Share | USD/shares | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-27 | 0000950170-25-045725 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-27 | 0000950170-25-045725 | |
| us-gaap | TemporaryEquitySharesIssued | Temporary Equity, Shares Issued | shares | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-27 | 0000950170-25-045725 | |
| us-gaap | TemporaryEquitySharesOutstanding | Temporary Equity, Shares Outstanding | shares | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-27 | 0000950170-25-045725 | |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 9.87M | 2025-12-31 | S-4/A | 2026-11-02 | 0001193125-26-442255 | |||
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 656,000 | 2025-01-01 | 2025-12-31 | S-4/A | 2026-11-02 | 0001193125-26-442255 | ||
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-27 | 0000950170-25-045725 |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 1.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 22.58M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 22.58M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-10 | 0001193125-26-454406 |